Tiziana Life Sciences Highlights Intranasal Foralumab for Moderate Alzheimer's Disease

Tiziana Life Sciences announced positive advancements in moderate Alzheimer's disease treatment using intranasal foralumab, a fully human anti-CD3 mon...
Home/KnloSights/Clinical Trial Updates/Tiziana Life Sciences Highlights Intranasal Foralumab for Moderate Alzheimer's Disease